164.34USD+4.19%Mkt Cap: 24.85B USDP/E: 29.81Last update: 2026-05-29
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap24.85B USD
Enterprise Value26.04B USD
Revenue (TTM)4.39B USD
Gross Profit2.87B USD
Net Income (TTM)850.00M USD
Revenue/Share28.62 USD
Last Price164.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)29.81
P/E (Forward)27.48
PEG2.78
EV/EBITDA22.55
EV/Revenue5.93
P/S5.61
P/B9.26
EPS (TTM)5.51
EPS (Forward)5.93
52W Range
78.7999% of range165.37
52W High165.37 USD
52W Low78.79 USD
Profitability
Gross Margin66.08%
Oper. Margin18.33%
EBITDA Margin26.29%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth4.80%
Earnings Growth6.10%
Cash Flow & Leverage
Operating CF1.08B USD
CapEx (TTM)148.00M USD
FCF Margin19.25%
FCF Yield3.40%
Net Debt1.39B USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.94
Current Ratio1.75
Quick Ratio1.23
Book Value/Sh17.61 USD
Cash/Share7.634 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1028:1000
Split DateJun 25, 2024
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)143.63 USD
Target Range95.00 USD – 175.00 USD
# Analysts19
Ownership
Shares Out.151.30M
Float147.38M
Insiders0.22%
Institutions106.53%
Short Interest
Short Ratio4.5d
Short % Float8.11%
Short % Out.4.96%
Shares Short7.50M
Short (prev mo.)7.18M
Technical
SMA 50132.99 (+23.6%)
SMA 200121.94 (+34.8%)
Beta1.42
S&P 52W Chg27.94%
Avg Vol (30d)1.54M
Avg Vol (10d)1.63M
Technical Indicators
RSI (14)79.5
MACD6.1038
MACD Signal4.5093
MACD Hist.+1.5946
BB Upper157.51 USD
BB Middle144.40 USD
BB Lower131.29 USD
BB Width18.16%
ATR (14)5.870 USD
Vol Ratio (20d)0.68x